Marcus (NYSE:MCS – Get Free Report) is anticipated to post its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect Marcus to post earnings of $0.5370 per share and revenue of $235.65 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, October 29, 2026 at 11:00 AM ET.
Marcus (NYSE:MCS – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.16. Marcus had a net margin of 2.87% and a return on equity of 2.67%. The company had revenue of $231.74 million for the quarter, compared to analyst estimates of $217.72 million. On average, analysts expect Marcus to post $0.83 EPS for the current fiscal year and $0.92 EPS for the next fiscal year.
Marcus Trading Down 0.3%
NYSE MCS opened at $27.90 on Tuesday. The stock has a market cap of $860.16 million, a P/E ratio of 39.30 and a beta of 0.58. The company’s fifty day simple moving average is $28.13 and its 200-day simple moving average is $21.71. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.34. Marcus has a 52 week low of $12.88 and a 52 week high of $32.42.
Marcus Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, August 25th were paid a dividend of $0.09 per share. This is a positive change from Marcus’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, August 25th. This represents a $0.36 annualized dividend and a yield of 1.3%. Marcus’s payout ratio is presently 50.70%.
Insiders Place Their Bets
In related news, Director Diane M. Gershowitz sold 50,000 shares of the business’s stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $27.61, for a total value of $1,380,500.00. Following the completion of the sale, the director directly owned 125,617 shares of the company’s stock, valued at $3,468,285.37. The trade was a 28.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 16.53% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of brokerages have commented on MCS. B. Riley Financial reiterated a “neutral” rating on shares of Marcus in a report on Monday, October 19th. Wall Street Zen upgraded Marcus from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 19th. Wedbush raised their target price on Marcus from $23.00 to $34.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Zacks Research lowered Marcus from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 2nd. Finally, Benchmark boosted their price target on Marcus from $22.00 to $33.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $32.25.
Check Out Our Latest Stock Analysis on Marcus
Marcus Company Profile
Marcus Corporation (NYSE: MCS) is an entertainment and hospitality company headquartered in Milwaukee, Wisconsin. Its principal businesses are conducted through Marcus Theatres and Marcus Hotels & Resorts.
Marcus Theatres operates movie theaters in the United States, primarily across the Midwest, under brands that include Marcus Theatres and Movie Tavern. Its theater operations offer film screenings, reserved seating, premium viewing formats, food and beverage service, and other cinema-related experiences.
Marcus Hotels & Resorts owns, manages, or operates hotels, resorts, restaurants, and related hospitality facilities in the United States.
Recommended Stories
- Five stocks we like better than Marcus
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Marcus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marcus and related companies with MarketBeat.com's FREE daily email newsletter.
